Centene signs definitive agreement to sell Circle Health to PureHealth

Centene announced that it has signed a definitive agreement to sell Circle Health to PureHealth. The transaction reflects Centene’s continued execution of its value creation efforts as the company refocuses its portfolio on core lines of business. The enterprise value is approximately $1.2B, inclusive of debt assumed. “Circle Health is an innovative healthcare organization that has had a significant impact for the benefit of patients across the United Kingdom. We are confident that this business will continue to thrive – providing access to high-quality care and delivering improved clinical outcomes under the ownership of Pure Health,” said Centene Chief Executive Officer, Sarah London. “This transaction marks another milestone in our portfolio review and showcases continued momentum against our value creation plan.” The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2024.